Skip to main content

Bijuva News

Certain Birth Control Pills, Devices Linked to Higher Heart Risks

THURSDAY, Feb. 13, 2025 – The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack and stroke, a new study finds. Contraceptive vaginal rings...

Tibolone, Oral Estrogen-Progestin Therapy Linked to Risk for Heart Disease

THURSDAY, Dec. 5, 2024 – Use of tibolone or oral estrogen-progestin therapy is associated with an increased risk for specific cardiovascular diseases, according to a study published online Nov. 27...

FDA Approves Bijuva (estradiol and progesterone) Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause

BOCA RATON, Fla.--(BUSINESS WIRE)--Oct. 29, 2018-- TherapeuticsMD, Inc, an innovative women’s healthcare company, today announced that the United States Food and Drug Administration (FDA) has a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Postmenopausal Symptoms, Menopausal Disorders, Hot Flashes

Bijuva patient information at Drugs.com